Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
Public ClinicalTrials.gov record NCT03032380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to compare all-cause mortality at Day 14 in participants receiving cefiderocol with participants receiving the comparator, meropenem, in adults with hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or healthcare-associated bacterial pneumonia (HCABP) caused by Gram-negative pathogens.
Study identification
- NCT ID
- NCT03032380
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2017 (Actual)
- Primary completion
- Feb 26, 2019 (Actual)
- Completion
- Apr 1, 2019 (Actual)
- Last update posted
- Nov 13, 2020
2017 – 2019
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shionogi Research Site | New Haven | Connecticut | 06511 | — |
| Shionogi Research Site | DeLand | Florida | 32720 | — |
| Shionogi Research Site | Chicago | Illinois | 60612 | — |
| Shionogi Research Site | Council Bluffs | Iowa | 51503 | — |
| Shionogi Research Site | Louisville | Kentucky | 40202 | — |
| Shionogi Research Site | Baton Rouge | Louisiana | 70808 | — |
| Shionogi Research Site | Shreveport | Louisiana | 71103 | — |
| Shionogi Research Site | Annapolis | Maryland | 21404 | — |
| Shionogi Research Site | Detroit | Michigan | 48201 | — |
| Shionogi Research Site | St Louis | Missouri | 63110-0250 | — |
| Shionogi Research Site | Cleveland | Ohio | 44106 | — |
| Shionogi Research Site | Columbus | Ohio | 43210-1267 | — |
| Shionogi Research Site | Bethlehem | Pennsylvania | 18105 | — |
| Shionogi Research Site | Philadelphia | Pennsylvania | 19141 | — |
| Shionogi Research Site | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03032380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03032380 live on ClinicalTrials.gov.